Global Hospital and Nursing Home Probiotics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hospital and Nursing Home Probiotics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Probiotics are live microorganisms intended to provide health benefits when consumed, generally by improving or restoring the gut flora.
Hospital and Nursing Home Probiotics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hospital and Nursing Home Probiotics market is projected to reach US$ 92 million in 2034, increasing from US$ 70 million in 2022, with the CAGR of 4.0% during the period of 2024 to 2034. Demand from Gut Health and Immunity are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hospital and Nursing Home Probiotics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Hospital and Nursing Home Probiotics key manufacturers include Bio - K Plus International, American Lifeline, Rising Pharmaceuticals, Becton Dickinson and Company, NutraScience Labs, Vitakem Nutraceuticals, Probium, Protexin and Nutraceutix, etc. Bio - K Plus International, American Lifeline, Rising Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Hospital and Nursing Home Probiotics can be divided into Lactobacillus, Bifidobacterium, Gram-positive Cocci and Others, etc. Lactobacillus is the mainstream product in the market, accounting for % sales share globally in 2022.
Hospital and Nursing Home Probiotics is widely used in various fields, such as Gut Health, Immunity, Wellness and Others, etc. Gut Health provides greatest supports to the Hospital and Nursing Home Probiotics industry development. In 2022, global % sales of Hospital and Nursing Home Probiotics went into Gut Health filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hospital and Nursing Home Probiotics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bio - K Plus International
American Lifeline
Rising Pharmaceuticals
Becton Dickinson and Company
NutraScience Labs
Vitakem Nutraceuticals
Probium
Protexin
Nutraceutix
Nebraska Cultures
Mercola
Eva Nutra
UP4 Probiotics
Segment by Type
Lactobacillus
Bifidobacterium
Gram-positive Cocci
Others
Gut Health
Immunity
Wellness
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Hospital and Nursing Home Probiotics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hospital and Nursing Home Probiotics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hospital and Nursing Home Probiotics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hospital and Nursing Home Probiotics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hospital and Nursing Home Probiotics introduction, etc. Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hospital and Nursing Home Probiotics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Hospital and Nursing Home Probiotics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hospital and Nursing Home Probiotics market is projected to reach US$ 92 million in 2034, increasing from US$ 70 million in 2022, with the CAGR of 4.0% during the period of 2024 to 2034. Demand from Gut Health and Immunity are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hospital and Nursing Home Probiotics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Hospital and Nursing Home Probiotics key manufacturers include Bio - K Plus International, American Lifeline, Rising Pharmaceuticals, Becton Dickinson and Company, NutraScience Labs, Vitakem Nutraceuticals, Probium, Protexin and Nutraceutix, etc. Bio - K Plus International, American Lifeline, Rising Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Hospital and Nursing Home Probiotics can be divided into Lactobacillus, Bifidobacterium, Gram-positive Cocci and Others, etc. Lactobacillus is the mainstream product in the market, accounting for % sales share globally in 2022.
Hospital and Nursing Home Probiotics is widely used in various fields, such as Gut Health, Immunity, Wellness and Others, etc. Gut Health provides greatest supports to the Hospital and Nursing Home Probiotics industry development. In 2022, global % sales of Hospital and Nursing Home Probiotics went into Gut Health filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hospital and Nursing Home Probiotics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bio - K Plus International
American Lifeline
Rising Pharmaceuticals
Becton Dickinson and Company
NutraScience Labs
Vitakem Nutraceuticals
Probium
Protexin
Nutraceutix
Nebraska Cultures
Mercola
Eva Nutra
UP4 Probiotics
Segment by Type
Lactobacillus
Bifidobacterium
Gram-positive Cocci
Others
Segment by Application
Gut Health
Immunity
Wellness
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Hospital and Nursing Home Probiotics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hospital and Nursing Home Probiotics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hospital and Nursing Home Probiotics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hospital and Nursing Home Probiotics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hospital and Nursing Home Probiotics introduction, etc. Hospital and Nursing Home Probiotics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hospital and Nursing Home Probiotics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices